| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/1995 | EP0632019A1 Acylureas |
| 01/04/1995 | EP0632017A1 N-phenyl-2-cyano-3-hydroxy propenamides, their tautomeres and salts, their use as medicaments and compositions containing them |
| 01/04/1995 | EP0632016A1 1,2-Diacylated hydrazine derivatives and their use as cell adhesion inhibitors |
| 01/04/1995 | EP0632008A1 Pentanoic acid derivatives |
| 01/04/1995 | EP0631784A1 Sulphated polysaccharides having anti-inflammatory activity |
| 01/04/1995 | EP0631783A1 Antiviral combinations of 2',3'-di-deoxyribonucleosides with 6-benzyl-1-ethoxymethyl-5-substituted uracil derivatives |
| 01/04/1995 | EP0631782A1 Stabilized solid pharmaceutical preparation containing dextromethorphan, phenylpropanolamine and caffeine |
| 01/04/1995 | EP0631781A1 Opioid formulations having extended controlled release |
| 01/04/1995 | EP0631780A1 Use of an angiotensin II antagonist as an ocular hypotensive agent |
| 01/04/1995 | EP0631779A1 Use of esters of L-carnitine and acyl L-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses |
| 01/04/1995 | EP0631778A1 Use of L-aspartate or L-asparagine to prevent alcohol toxicity |
| 01/04/1995 | EP0631777A1 Use of derivatives of beta-naphthoquinone for inhibiting platelet aggregation |
| 01/04/1995 | EP0631776A1 Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631583A1 Antiviral phosphonic acid derivatives of purine analogues |
| 01/04/1995 | EP0631580A1 PYRIDO 2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS |
| 01/04/1995 | EP0631578A1 Itraconazole and saperconazole stereoisomers |
| 01/04/1995 | EP0631576A1 Dipeptidylquinazolones as anti-cancer agents |
| 01/04/1995 | EP0631570A1 Compounds |
| 01/04/1995 | EP0631505A1 Use of a peptide |
| 01/04/1995 | EP0631503A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 01/04/1995 | EP0631500A1 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4 |
| 01/04/1995 | EP0631474A1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use |
| 01/04/1995 | EP0631472A1 Antiviral contraceptive devices, particularly condoms |
| 01/04/1995 | EP0630381A4 Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives. |
| 01/04/1995 | EP0561941B1 N-substituted lactams useful as cholecystokinin antagonists |
| 01/04/1995 | EP0536173B1 Pyridopyrazine derivatives for treating substance abuse and addiction |
| 01/04/1995 | EP0470231B1 Composition and use of the composition for the manufacture of a medicament for the treatment of injuries caused by the radiation of heat and light |
| 01/04/1995 | CN1097011A Medicine for curing enteritis and ulcer colitis and prepn. method thereof |
| 01/04/1995 | CN1097010A New compound |
| 01/04/1995 | CN1097006A O-aryl ethers of morphinans |
| 01/04/1995 | CN1097005A Chemical compounds |
| 01/04/1995 | CN1096946A Analgesic liniment for rheumatic arthritis patient |
| 01/04/1995 | CN1027288C Method for producing of PF1022 substance and anthelmintic composition containing same |
| 01/04/1995 | CN1027271C Method for preparation of polypeptide with nor-state and nor-cyclostatine |
| 01/04/1995 | CN1027270C 14,17 beta-ehano-14 beta-estratrienes and estratetranenes, process for their production and pharmaceutical preparations containing them |
| 01/04/1995 | CN1027268C Method for preparation of new benzopyranone-beta-D-thioxylosides |
| 01/04/1995 | CN1027267C Method for preparing of N-acyl derivatives of LL-E33288 antitumor antibiotics |
| 01/04/1995 | CN1027265C Process for preparing of water-soluble camptothecin analogues |
| 01/04/1995 | CN1027264C Process for preparing castano spermine glycosides |
| 01/04/1995 | CN1027263C Method for preparation of pyridopyrimidine derivatives |
| 01/04/1995 | CN1027262C Preparing of benzazepine and benzothiazepine derivatives |
| 01/03/1995 | US5378848 Benzodiazepine agonist, psychotropic, antianxiety, cerebral function activator, anesthesia atagonist |
| 01/03/1995 | US5378838 For use in humans |
| 01/03/1995 | US5378837 Process for preparing 2'-(diethylamino)rifamycin P (P/DEA) |
| 01/03/1995 | US5378835 Water solubile salt from pheophorbide and sodium hydroxide |
| 01/03/1995 | US5378825 Backbone modified oligonucleotide analogs |
| 01/03/1995 | US5378732 Method of reducing the rate of reocclusion of arteries |
| 01/03/1995 | US5378731 Process for cleaning, conditioning, disinfecting and moisturizing hair using fatty esters, chelate compounds, detergents and conditioners |
| 01/03/1995 | US5378729 Diamide derivatives |
| 01/03/1995 | US5378725 Administering as antitumor or anticarcinogenic agent to mammals |
| 01/03/1995 | US5378723 Cholinergic agonist and blocking agents |
| 01/03/1995 | US5378722 Nutritional compositions for management of nitrogen metabolism |
| 01/03/1995 | US5378721 Aromatase inhibitors |
| 01/03/1995 | US5378720 Treatment of rheumatoid arthritis, emphysema, pancreatitis |
| 01/03/1995 | US5378719 Antiarthritic agents; rheumatic diseases |
| 01/03/1995 | US5378718 Cardiovascular activity, hypotensive |
| 01/03/1995 | US5378717 Vision defects and cardiovascular disorders |
| 01/03/1995 | US5378716 Pyrazol-1-yl phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 01/03/1995 | US5378713 Substituted thienopyrans as antihypertensive agents |
| 01/03/1995 | US5378712 Antithrombosis |
| 01/03/1995 | US5378710 17β-substituted aza-androstane derivatives |
| 01/03/1995 | US5378709 Administering 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine or a pharmaceutically acceptable salt thereof to mammals |
| 01/03/1995 | US5378702 Thiadizinones |
| 01/03/1995 | US5378700 Fused pyrimidine derivative, process for preparation of same and pharmaceutical preparation comprising same as active ingredient |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | US5378698 Benzothiazepine derivatives |
| 01/03/1995 | US5378697 Cephalosporins |
| 01/03/1995 | US5378694 Acyl and alkoxy substituted quinolines |
| 01/03/1995 | US5378693 Antitumor agents or viricides |
| 01/03/1995 | US5378689 Peptides having renin inhibitory activity, their preparation and use |
| 01/03/1995 | US5378617 Process for the production of macrolide compounds |
| 01/03/1995 | US5378475 Sustained release drug delivery devices |
| 01/03/1995 | US5378473 Transdermal administration of short or intermediate half-life benzodiazepines |
| 01/03/1995 | US5378472 Modified with levulinic acid |
| 01/03/1995 | US5378468 Orthoester which produces a fragrant material by hydrolysis at the ph of the skin when applied; deodorant sticks |
| 01/03/1995 | US5378461 Balsam mixture of a benzoquinone with vitamins A, E, and D carried by squalene or squalane |
| 01/03/1995 | US5378456 Antitumor mitoxantrone polymeric compositions |
| 01/03/1995 | US5378453 Composition for promoting melanin formation for hair coloring |
| 01/03/1995 | US5378451 Topical medicinal pressurized aerosol compositions and method of preparation, method of use and article of manufacture thereof |
| 01/03/1995 | US5378131 Chewing gum with dental health benefits employing calcium glycerophosphate |
| 01/03/1995 | CA2127318A1 Imidazole compounds and use thereof |
| 01/03/1995 | CA2127202A1 Ocular hypotensive agent |
| 01/03/1995 | CA2099557A1 Sustained release suppositories and a process for preparation |
| 01/03/1995 | CA2027394C 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/03/1995 | CA1333802C Substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives |
| 01/03/1995 | CA1333801C Heterazole dialkanoic acids |
| 01/03/1995 | CA1333775C Injectable solutions containing pyridine derivatives |
| 01/03/1995 | CA1333774C Soft capsular preparation of sodium picosulfate |
| 01/03/1995 | CA1333773C Antitussive liquid compositions containing phenol |
| 01/03/1995 | CA1333772C Method of treatment for arthritic and inflammatory diseases |
| 01/03/1995 | CA1333771C Use of imexon as an immune suppressive and pharmaceutical compositions containing them |
| 01/02/1995 | CA2127187A1 Anti-picornaviral agents |
| 12/31/1994 | CA2127085A1 Stabilized solid pharmaceutical preparation and method of producing the same |
| 12/31/1994 | CA2127066A1 .alpha.-amino acids derivatives, their preparation process and pharmaceutical compositions containing them |
| 12/31/1994 | CA2126994A1 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 12/31/1994 | CA2126039A1 Composition |
| 12/30/1994 | CA2126966A1 Pharmaceutical composition containing quinoline or quinazoline derivatives |
| 12/29/1994 | CA2126709A1 Angiotensin (aii) antagonists as inhibitors of the growth of adipose tissue |